BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parajuli DR, Kourbelis C, Franzon J, Newman P, Mckinnon RA, Shakib S, Whitehead D, Clark RA. Effectiveness of the Pharmacist-Involved Multidisciplinary Management of Heart Failure to Improve Hospitalizations and Mortality Rates in 4630 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Cardiac Failure 2019;25:744-56. [DOI: 10.1016/j.cardfail.2019.07.455] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Huynh S, Rush L, Dadalias D, Githinji D, Ta M, Poole SG, Percival M, Bell C, Warner V, Nguyen D. Time and motion study quantifying the activities of the cardiology, respiratory and geriatric clinical pharmacist. Pharmacy Practice and Res. [DOI: 10.1002/jppr.1825] [Reference Citation Analysis]
2 Rana K, Jay J, Patel S, Sueta C, Deyo Z. A Retrospective Cohort Evaluation of a Pharmacist-Led Approach for Transitioning Patients to an Angiotensin Receptor-Neprilysin Inhibitor. J Pharm Pract 2022;:8971900221087087. [PMID: 35392695 DOI: 10.1177/08971900221087087] [Reference Citation Analysis]
3 Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2021.12.012] [Cited by in Crossref: 70] [Cited by in F6Publishing: 34] [Article Influence: 70.0] [Reference Citation Analysis]
4 White CM. Pharmacists Have the Stats but No Provider Status: Now May Be Our Moment. Ann Pharmacother 2022;:10600280211036160. [PMID: 35107031 DOI: 10.1177/10600280211036160] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Wyman JF, Burns MR. Tricuspid Valve: A Heart Team Approach. Tricuspid Valve Disease 2022. [DOI: 10.1007/978-3-030-92046-3_11] [Reference Citation Analysis]
6 Tsutsui H, Ide T, Ito H, Kihara Y, Kinugawa K, Kinugawa S, Makaya M, Murohara T, Node K, Saito Y, Sakata Y, Shimizu W, Yamamoto K, Bando Y, Iwasaki YK, Kinugasa Y, Mizote I, Nakagawa H, Oishi S, Okada A, Tanaka A, Akasaka T, Ono M, Kimura T, Kosaka S, Kosuge M, Momomura SI. JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure. J Card Fail 2021:S1071-9164(21)00208-6. [PMID: 34600838 DOI: 10.1016/j.cardfail.2021.04.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
7 Davis LE, Pogge EK. Outcome Benefits Seen With 1 Year of Optimized Sacubitril/Valsartan for the Treatment of Systolic Heart Failure Managed by Pharmacists in a Cardiology Practice. Ann Pharmacother 2021;:10600280211036149. [PMID: 34459280 DOI: 10.1177/10600280211036149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Berei T, Forsyth P, Balakumaran K, Harshaw-Ellis K, Koshman S, Rasmusson K. Implementing Nonphysician Provider Guideline-Directed Medical Therapy Heart Failure Clinics: A Multi-National Imperative. J Card Fail 2021;27:896-906. [PMID: 34364666 DOI: 10.1016/j.cardfail.2021.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 Saposnik G, Saposnik F, Saposnik P. Rethinking adherence to home care in heart failure: the lessons learned from Diego Maradona's death. Home Health Care Serv Q 2021;:1-12. [PMID: 34284687 DOI: 10.1080/01621424.2021.1945519] [Reference Citation Analysis]
10 Schumacher PM, Becker N, Tsuyuki RT, Griese-Mammen N, Koshman SL, McDonald MA, Bouvy M, Rutten FH, Laufs U, Böhm M, Schulz M. The evidence for pharmacist care in outpatients with heart failure: a systematic review and meta-analysis. ESC Heart Fail 2021. [PMID: 34240570 DOI: 10.1002/ehf2.13508] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Cao VF, Cowley E, Koshman SL, Macgillivray J, Sidsworth M, Turgeon RD. Pharmacist‐led optimization of heart failure medications: A systematic review. J Am Coll Clin Pharm 2021;4:862-870. [DOI: 10.1002/jac5.1450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kolasa J, Lisiak M, Grabowski M, Jankowska EA, Lelonek M, Nessler J, Pawlak A, Uchmanowicz I. Factors Associated with Heart Failure Knowledge and Adherence to Self-Care Behaviors in Hospitalized Patients with Acute Decompensated Heart Failure Based on Data from "the Weak Heart" Educational Program. Patient Prefer Adherence 2021;15:1289-300. [PMID: 34163146 DOI: 10.2147/PPA.S297665] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Benge C, Pouliot J, Muldowney JAS 3rd. Evaluation of a Clinical Pharmacist Specialist Transition of Care Pathway to Manage Heart Failure Readmissions During a Provider Shortage. J Pharm Pract 2021;:8971900211017484. [PMID: 34060365 DOI: 10.1177/08971900211017484] [Reference Citation Analysis]
14 Arunmanakul P, Kengkla K, Chaiyasothi T, Phrommintikul A, Ruengorn C, Permsuwan U, Thakkinstian A, Page RL, Munger MA, Nathisuwan S, Chaiyakunapruk N. Effects of pharmacist interventions on heart failure outcomes: A systematic review and meta‐analysis. J Am Coll Clin Pharm 2021;4:871-82. [DOI: 10.1002/jac5.1442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
15 Parajuli DR, Shakib S, Eng-Frost J, McKinnon RA, Caughey GE, Whitehead D. Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients. BMC Cardiovasc Disord 2021;21:104. [PMID: 33602125 DOI: 10.1186/s12872-021-01868-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hani N, Zachariah S, Thomas D, Cooper JC. Pharmacist-led heart failure patient focus group using mobile apps-based intervention mix. Journal of Pharmaceutical Health Services Research 2021;12:30-4. [DOI: 10.1093/jphsr/rmaa003] [Reference Citation Analysis]
17 Schulz M, Griese-Mammen N, Schumacher PM, Anker SD, Koehler F, Ruckes C, Rettig-Ewen V, Wachter R, Trenk D, Böhm M, Laufs U. The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial. ESC Heart Fail 2020. [PMID: 32700409 DOI: 10.1002/ehf2.12904] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 Al AdAwi RM, Stewart D, Ryan C, Tonna AP. A systematic review of pharmacist input to metabolic syndrome screening, management and prevention. Int J Clin Pharm 2020;42:995-1015. [PMID: 32607719 DOI: 10.1007/s11096-020-01084-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 Atallah B, Sadik ZG, Osoble AA, Ghalib H, Hamour I, Altakruri M, Ferrer R, Cherfan A, Bader F. Establishing the first pharmacist‐led heart failure medication optimization clinic in the Middle East Gulf Region. J Am Coll Clin Pharm 2020;3:877-84. [DOI: 10.1002/jac5.1219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]